Industry

Investor Webcast and Conference Call Scheduled for 5:00 p.m. EST SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced clearance by the Food and Drug Administration of its previously disclosed 510(k) submission and resumption … [Read more…]

The five-year, multisite study will look at how physical activity before and after surgery affects recovery in an older patient population. LOS ANGELES–(BUSINESS WIRE)–City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that it has been approved for nearly $7 million from the Patient-Centered Outcomes Research … [Read more…]

Only Health System in the Nation to Receive National Level Recognition ONTARIO, Calif.–(BUSINESS WIRE)–#EisenbergAwards–Prime Healthcare, one of the nation’s leading health systems, has been recognized with the prestigious 2021 John M. Eisenberg Patient Safety and Quality Award in the “National Level Innovation in Patient Safety and Quality” category. Prime Healthcare was recognized for its cohesive … [Read more…]

The BrainCheck IIR Grant is looking to fund research that aids in the early detection and treatment of patient pools experiencing cognitive decline. SAN DIEGO–(BUSINESS WIRE)–BrainCheck Inc., developer of an innovative digital cognitive assessment and care platform, today announced an Investigator Initiated Research (IIR) Grant Program to help fund research for evaluation, diagnosis, treatment and … [Read more…]

Delivering unparalleled intelligence and insights to help healthcare leaders strategically determine where, when, and how to grow CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced it has completed the acquisition of Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. Syntellis announced … [Read more…]

Company Expands Reach and Patient Access in the Pharmacy Market ORLANDO, Fla.–(BUSINESS WIRE)–Transaction Data Systems (TDS), the leader in pharmacy software solutions, today announced the successful completion of its acquisition of PrescribeWellness from Tabula Rasa HealthCare, Inc.® (TRHC). PrescribeWellness is a market-leading patient relationship management company with a proven track record of facilitating patient, payor, … [Read more…]

PARSIPPANY, N.J.–(BUSINESS WIRE)–#ExtremityMedical–Extremity Medical, LLC, a global medical device company focused on the development of innovative implants and instruments for upper and lower extremities, today announced that it has received an award for the Vizient Inc., National Small Joints Category. The awarded contract includes all Extremity Medical’s Upper and Lower Extremity systems, including the innovative … [Read more…]

Medallia joins select group of leading companies focused on elevating humanism in healthcare and improving patient experience PLEASANTON, Calif.–(BUSINESS WIRE)–Medallia, Inc., the global leader in customer and employee experience, today announced its partnership with The Arnold P. Gold Foundation as a Gold Corporate Council Member. The Gold Foundation champions humanism in healthcare, which it defines … [Read more…]

Topline results expected early Q4 2022 `S-HERTOGENBOSCH, Netherlands–(BUSINESS WIRE)–Amphera B.V., a late-stage biotechnology company developing cell therapies to treat cancer, announces that the last patient has completed the active follow-up in the Phase II/III DENIM study of MesoPher cell therapy to treat pleural mesothelioma. Ilona Enninga PhD, COO of Amphera said: “Despite the challenges experienced … [Read more…]

Funding will accelerate development of novel disease-modifying targeted protein degraders against high value precision oncology targets SAN DIEGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Differentiated Therapeutics (dx/tx), a biotech company focused on computationally predicting and optimizing targeted protein degraders (TPDs), today announced the completion of a $5 million Seed financing. Curie.Bio, a founder-focused seed-stage venture capital firm, financed … [Read more…]